Global eye health company Bausch + Lomb (B+L) sent a letter yesterday to ophthalmologists highlighting recent ways they are enhancing and expanding their product portfolio, as well as their upcoming presence at the annual American Society of Cataract and Refractive Surgery (ASCRS) conference.
Addressed from U.S. Surgical General Manager and Senior Vice President Andrew Chang, the letter announced B+L had recently received FDA approval for several enhancements to its Trulign® Toric IOL calculator. Additionally, B+L is planning to launch its new FortifEYE™ capsular tension ring (CTR) and plan to file for FDA approval in the coming months.
And B+L plans to exhibit at ASCRS 2016, as well as support a number of events and exhibits including booth talks, education courses, research symposia, and technology and innovation showcase.
Click here to read the full letter.